Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 1.0 | 61.3 | 43.3 | 24.6 | 21.2 | 12.1 | 7.8 | 7.2 |
Revenue growth | -77.3% | 41.5% | 76.1% | 16.0% | 74.9% | 56.5% | 7.4% | 11.0% |
Cost of goods sold | 23.5 | 25.7 | 19.2 | 9.2 | 9.0 | 6.2 | 3.4 | 3.6 |
Gross profit | -22.5 | 35.6 | 24.1 | 15.4 | 12.2 | 6.0 | 4.3 | 3.6 |
Gross margin | -2191.1% | 58.1% | 55.7% | 62.8% | 57.6% | 49.1% | 56.0% | 49.8% |
Selling, general and administrative | 53.5 | 27.7 | | | | | | 4.2 |
Sales and marketing | 20.0 | | | | | | | |
Research and development | | | | | | | | |
General and administrative | | 27.7 | 21.0 | 15.6 | 9.2 | 6.9 | 5.1 | |
EBIT | -12.3 | 0.4 | -2.3 | -4.3 | 0.2 | -2.1 | -1.5 | -0.6 |
EBIT margin | -1199.1% | 8.0% | -5.3% | -17.6% | 0.8% | -17.6% | -19.8% | -8.3% |
Pre-tax income | -11.4 | 0.4 | -2.2 | -4.0 | 0.2 | -2.1 | -1.5 | -0.6 |
Income taxes | 0.0 | 0.0 | 0.0 | -0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 22.2% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -11.4 | 0.4 | -2.2 | -3.1 | 0.2 | -2.1 | -1.5 | -0.6 |
Net margin | -1115.9% | 8.4% | -5.1% | -12.8% | 1.1% | -17.3% | -19.9% | -8.2% |
|
Diluted EPS | ($0.64) | $0.02 | ($0.15) | ($0.23) | $0.02 | ($0.21) | ($0.05) | ($0.02) |
Shares outstanding (diluted) | 17.8 | 17.7 | 14.8 | 13.4 | 11.9 | 9.8 | 29.7 | 24.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|